article thumbnail

Stroke Survivors With Afib Could Start DOACs Earlier

Med Page Today

(MedPage Today) -- It was safe to start direct oral anticoagulant (DOAC) therapy without delay after acute ischemic stroke in people with atrial fibrillation (Afib), according to the OPTIMAS randomized trial. Stroke survivors randomized to early.

AFIB 109
article thumbnail

Big Blow to Anticoagulation Strategy Against Afib-Related Cognition Problems

Med Page Today

(MedPage Today) -- CHICAGO -- Researchers failed to prevent cognitive impairment in people with existing atrial fibrillation (Afib) by going the route of anticoagulation to mitigate subclinical brain infarcts, according to the BRAIN-AF trial.

AFIB 90
article thumbnail

AFib Might Be Far More Common Than We Think

CardiacWire

A JACC study suggests that atrial fibrillation is far more prevalent than many previously thought, estimating that nearly one in 20 American adults have been diagnosed with the disease. age, 54% women, 50% White), finding that a whopping 2M (6.8%) of them had been diagnosed with AFib. adults would have AFib by 2020.

AFIB 105
article thumbnail

Afib Ablation Delivers in First Sham-Controlled Study

Med Page Today

(MedPage Today) -- LONDON -- Pulmonary vein isolation (PVI) produced real short-term improvements for people with atrial fibrillation (Afib or AF), according to the first sham-controlled trial on the subject. Continuous monitoring by implantable.

AFIB 107
article thumbnail

Boston Scientific Bolsters AFib Mapping with Cortex Acquisition

CardiacWire

Boston Scientific made what could become a major addition to its electrophysiology portfolio, acquiring AFib mapping startup Cortex, Inc. Cortex gives Boston Scientific a new mapping technology that detects AFib signs and triggers outside of the pulmonary veins, and can help EP teams develop ablation strategies for more complex AFib cases.

AFIB 105
article thumbnail

Which Anticoagulant Is Safest for Afib Patients With Cirrhosis?

Med Page Today

(MedPage Today) -- Apixaban (Eliquis) was associated with lower serious bleeding rates than rivaroxaban (Xarelto) or warfarin in patients with cirrhosis and atrial fibrillation (AF, Afib) in a nationwide cohort study. Among more than 12,000 such.

AFIB 109
article thumbnail

Serious Issues With Slow Heartbeat Flagged for Afib Patients on Antiarrhythmics

Med Page Today

(MedPage Today) -- Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic drugs (AADs) had several-fold.

AFIB 123